{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:00:48Z","timestamp":1746504048507,"version":"3.40.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Central nervous system (CNS) involvement is common in histiocytosis, yet cerebrospinal fluid (CSF) analysis often yields normal results. We present three cases of monocytic meningitis associated with histiocytosis. The first patient was diagnosed with Erdheim-Chester disease (ECD) and exhibited evidence of a MAP2K1 mutation, concomitant with chronic myelomonocytic leukemia. Brain magnetic resonance imaging (MRI) revealed leptomeningitis and pachymeningitis. The presence of the same MAP2K1 mutation in CSF monocytes confirmed the clonal origin of neuromeningeal infiltration. Treatment with binimetinib rapidly improved the patient\u2019s clinical condition. The second case involved CNS primary malignant histiocytosis (CNS-PMH) associated with myelodysplastic syndrome. However, treatment with binimetinib only led to a partial and time-limited response. The last patient was diagnosed with mixed histiocytosis ECD\/Rosai-Dorfman disease (RDD). Cobimetinib also proved effective in managing CNS symptoms. CSF pleocytosis in CNS involvement of histiocytosis has been reported in a few published cases with neurological involvement. Given its rarity, the presence of monocytic meningitis should prompt immediate suspicion of histiocytosis, particularly if accompanied by typical manifestations. In cases of neurological involvement in histiocytosis, lumbar puncture and liquid biopsy can sometime overcome the need for a meningeal biopsy. The molecular characterization of histiocytosis is essential for considering the use of targeted therapy, but the lack of an identified mutation should not preclude the use of anti-MEK therapy.<\/jats:p>","DOI":"10.1007\/s00277-025-06317-x","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T16:43:27Z","timestamp":1743093807000},"page":"2551-2557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monocytic meningitis complicating histiocytosis and response to MEK-inhibitor: a case series"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9931-0411","authenticated-orcid":false,"given":"Tom","family":"Abrassart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Idbaih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Galanaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fleur","family":"Cohen-Aubart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Emile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Boncoeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Seilhean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Papo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"22","key":"6317_CR1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S et al (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127(22):2672\u20132681. https:\/\/doi.org\/10.1182\/blood-2016-01-690636","journal-title":"Blood"},{"issue":"4","key":"6317_CR2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/bjh.15577","volume":"183","author":"S H\u00e9ritier","year":"2018","unstructured":"H\u00e9ritier S, Barkaoui M, Miron J et al (2018) Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study. Br J Haematol 183(4):608\u2013617. https:\/\/doi.org\/10.1111\/bjh.15577","journal-title":"Br J Haematol"},{"issue":"16","key":"6317_CR3","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1182\/blood.2019002766","volume":"135","author":"J Haroche","year":"2020","unstructured":"Haroche J, Cohen-Aubart F, Amoura Z (2020) Erdheim-Chester disease. Blood 135(16):1311\u20131318. https:\/\/doi.org\/10.1182\/blood.2019002766","journal-title":"Blood"},{"key":"6317_CR4","doi-asserted-by":"publisher","unstructured":"Cohen Aubart F, Idbaih A, Galanaud D et al (2020) Central nervous system involvement in Erdheim-Chester disease: an observational cohort study. Neurology 95(20). https:\/\/doi.org\/10.1212\/WNL.0000000000010748","DOI":"10.1212\/WNL.0000000000010748"},{"issue":"2","key":"6317_CR5","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/S1470-2045(17)30031-1","volume":"18","author":"J Haroche","year":"2017","unstructured":"Haroche J, Cohen-Aubart F, Rollins BJ et al (2017) Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol 18(2):e113\u2013e125. https:\/\/doi.org\/10.1016\/S1470-2045(17)30031-1","journal-title":"Lancet Oncol"},{"issue":"11","key":"6317_CR6","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s10072-016-2636-4","volume":"37","author":"T Ueno","year":"2016","unstructured":"Ueno T, Nishijima H, Kurotaki H, Kurose A, Tomiyama M (2016) An unusual case of chronic meningitis due to Histiocytic sarcoma of the central nervous system with meningeal dissemination. Neurol Sci 37(11):1875\u20131877. https:\/\/doi.org\/10.1007\/s10072-016-2636-4","journal-title":"Neurol Sci"},{"issue":"9","key":"6317_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1212\/WNL.0000000000012155","volume":"97","author":"ME Nothem","year":"2021","unstructured":"Nothem ME, Lee RM, Katz JM, Bergl PA, Obeidat AZ (2021) Clinical reasoning: A 42-Year-Old woman with mysterious monocytic meningitis. Neurology 97(9):449\u2013454. https:\/\/doi.org\/10.1212\/WNL.0000000000012155","journal-title":"Neurology"},{"issue":"37","key":"6317_CR8","doi-asserted-by":"publisher","first-page":"e30585","DOI":"10.1097\/MD.0000000000030585","volume":"101","author":"C Polk","year":"2022","unstructured":"Polk C, Weida C, Patel N, Leonard M (2022) Erdheim-Chester disease presenting as meningitis with hypoglycorrhachia: A case report. Medicine 101(37):e30585. https:\/\/doi.org\/10.1097\/MD.0000000000030585","journal-title":"Medicine"},{"issue":"3","key":"6317_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/mpo.2950080308","volume":"8","author":"A Carbone","year":"1980","unstructured":"Carbone A, Tirelli U, Volpe R et al (1980) Malignant histiocytosis in adults: report of 7 patients from North East Italy. Med Pediatr Oncol 8(3):265\u2013274. https:\/\/doi.org\/10.1002\/mpo.2950080308","journal-title":"Med Pediatr Oncol"},{"issue":"7","key":"6317_CR10","first-page":"981","volume":"33","author":"S Fujisawa","year":"1992","unstructured":"Fujisawa S, Motomura S, Fujita H et al (1992) [Malignant histiocytosis associated with central neurological symptoms and cerebrospinal fluid involvement]. Rinsho Ketsueki 33(7):981\u2013985","journal-title":"Rinsho Ketsueki"},{"issue":"4","key":"6317_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2176\/nmc.34.233","volume":"34","author":"S Hirose","year":"1994","unstructured":"Hirose S, Shimada S, Takebe Y, Tokuriki Y, Kawano H, Kubota T (1994) Recurrent malignant histiocytosis with cerebrospinal Involvement - Case report. Neurol Med Chir(Tokyo) 34(4):233\u2013236. https:\/\/doi.org\/10.2176\/nmc.34.233","journal-title":"Neurol Med Chir(Tokyo)"},{"issue":"2","key":"6317_CR12","first-page":"187","volume":"140","author":"S Schr\u00f6der","year":"1994","unstructured":"Schr\u00f6der S, Iglesias-Rozas JR, M\u00fcller U et al (1994) [Malignant meningeal histiocytosis]. Zentralbl Pathol 140(2):187\u2013194","journal-title":"Zentralbl Pathol"},{"issue":"5","key":"6317_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/jnnp.69.5.675","volume":"69","author":"T Stojkovic","year":"2000","unstructured":"Stojkovic T (2000) Atypical form of non-Langerhans histiocytosis with disseminated brain and leptomeningeal lesions. J Neurol Neurosurg Psychiatry 69(5):675\u2013678. https:\/\/doi.org\/10.1136\/jnnp.69.5.675","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"6317_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/1097-0339(200102)24:2<123::aid-dc1023>3.0.co;2-u","volume":"24","author":"N Ghosal","year":"2001","unstructured":"Ghosal N, Kapila K, Kakkar S, Verma K (2001) Langerhans cell histiocytosis infiltration in cerebrospinal fluid: a case report. Diagn Cytopathol 24(2):123\u2013125. https:\/\/doi.org\/10.1002\/1097-0339(200102)24:2%3C123::aid-dc1023%3E3.0.co;2-u","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"6317_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mpo.10380","volume":"41","author":"H Prosch","year":"2003","unstructured":"Prosch H, Feldges A, Grois N et al (2003) Demonstration of CD1a positive cells in the cerebrospinal fluid\u2014A clue to diagnosis of isolated Langerhans cell histiocytosis of the hypothalamic\u2014pituitary axis? Med Pediatr Oncol 41(5):474\u2013476. https:\/\/doi.org\/10.1002\/mpo.10380","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"6317_CR16","first-page":"539","volume":"12","author":"N Colovic","year":"2007","unstructured":"Colovic N, Jurisic V, Colovic M (2007) Malignant histiocytosis with central nervous system involvement and hepatic mucinous cystadenoma in a single patient with review of the literature. J BUON 12(4):539\u2013542","journal-title":"J BUON"},{"issue":"1","key":"6317_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/dc.20742","volume":"36","author":"SK Kraeft","year":"2008","unstructured":"Kraeft SK, Honig M, Krishnamurthy S (2008) Emperipolesis in the cerebrospinal fluid from a patient with Rosai-Dorfman disease. Diagn Cytopathol 36(1):67\u201368. https:\/\/doi.org\/10.1002\/dc.20742","journal-title":"Diagn Cytopathol"},{"issue":"1\u20132","key":"6317_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jns.2011.10.002","volume":"314","author":"A Nalini","year":"2012","unstructured":"Nalini A, Jitender S, Anantaram G, Santosh V (2012) Rosai Dorfman disease: case with extensive dural involvement and cerebrospinal fluid pleocytosis. J Neurol Sci 314(1\u20132):152\u2013154. https:\/\/doi.org\/10.1016\/j.jns.2011.10.002","journal-title":"J Neurol Sci"},{"issue":"16","key":"6317_CR19","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1212\/WNL.0000000000000880","volume":"83","author":"A Idbaih","year":"2014","unstructured":"Idbaih A, Mokhtari K, Emile JF et al (2014) Dramatic response of a BRAF V600E-mutated primary CNS Histiocytic sarcoma to Vemurafenib. Neurology 83(16):1478\u20131480. https:\/\/doi.org\/10.1212\/WNL.0000000000000880","journal-title":"Neurology"},{"issue":"2","key":"6317_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4143\/crt.2013.163","volume":"47","author":"H So","year":"2014","unstructured":"So H, Kim SA, Yoon DH et al (2014) Primary Histiocytic sarcoma of the central nervous system. Cancer Res Treat 47(2):322\u2013328. https:\/\/doi.org\/10.4143\/crt.2013.163","journal-title":"Cancer Res Treat"},{"key":"6317_CR21","doi-asserted-by":"publisher","unstructured":"Duarte-Celada WR, Thakolwiboon S, Brandi L, Duarte-Celada C, Avila M (2020) Adult Langerhans cell histiocytosis of the central nervous system. Baylor University Medical Center Proceedings. 33(4):603\u2013605. https:\/\/doi.org\/10.1080\/08998280.2020.1772184","DOI":"10.1080\/08998280.2020.1772184"},{"key":"6317_CR22","doi-asserted-by":"publisher","unstructured":"Tommasino F, Cardamone C, Tortora V, Sabbatino F, Di Sarno C, Caputo A (2022) Diagnosis of Langerhans cell histiocytosis on cytological examination of cerebrospinal fluid: report of the first case. Diagn Cytopathol 50(12). https:\/\/doi.org\/10.1002\/dc.25040","DOI":"10.1002\/dc.25040"},{"issue":"1","key":"6317_CR23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00415-023-11983-w","volume":"271","author":"V Pieri","year":"2024","unstructured":"Pieri V, Berzero G, Paterra R et al (2024) Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester\/Rosai-Dorfman disease. J Neurol 271(1):575\u2013579. https:\/\/doi.org\/10.1007\/s00415-023-11983-w","journal-title":"J Neurol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06317-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06317-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06317-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:14:10Z","timestamp":1746414850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06317-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6317"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06317-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients provided written informed consent (clinical trial registration NCT04437381 [Molecular Targets for the Treatment of Histiocytosis HISTIO-TARGET]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}